Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients

Kidney Int. 2000 Aug;58(2):790-9. doi: 10.1046/j.1523-1755.2000.00228.x.

Abstract

Background: 8-Hydroxy 2'-deoxyguanosine (8-OHdG) of leukocyte DNA has been identified as a surrogate marker of oxidative stress in chronic hemodialysis (HD) patients. In this study, we focused on the determinants of the 8-OHdG level in leukocyte DNA of HD patients. We further investigated the influence of vitamin E-modified, regenerated cellulose (CL-E) membrane on the oxidative DNA damage, intracellular reactive oxygen species (ROS) production of granulocytes, and plasma alpha-tocopherol concentration.

Methods: 8-OHdG content in cellular DNA of leukocytes was measured by a high-performance liquid chromatography-electrochemical detection (HPLC-ECD) method. Intracellular production of ROS, H2O2 and O2-. were analyzed by flow cytometry in leukocytes with and without phorbol-12-myristate-13-acetate (PMA) stimulation before dialysis, as well as at 15 and 30 minutes of dialysis. Plasma alpha-tocopherol concentration was measured by a HPLC method, and the value of alpha-tocopherol was corrected by total blood lipid concentration.

Results: In the prospective cross sectional study, the mean 8-OHdG level in leukocyte DNA was equally lower in the patients of the CL-E, polymethylmethacrylate (PMMA), and polysulfone (PS) groups as compared with the cellulosic group (ANOVA, P < 0.001). The leukocyte 8-OHdG level correlated negatively with plasma alpha-tocopherol and blood lipid-adjusted plasma alpha-tocopherol, but correlated positively with serum iron and percentage of transferrin saturation. Forward stepwise multiple regression showed that dialysis membrane type, serum iron, and blood lipid-adjusted plasma alpha-tocopherol were the independent determinants of the leukocyte 8-OHdG level in HD patients. Like synthetic membranes, granulocyte ROS production was less augmented during dialysis with the CL-E membrane as compared with the cellulose membrane. Exposure to cellulose membrane impaired intracellular ROS production of granulocytes in response to PMA challenge, whereas the CL-E and synthetic membranes improved the granulocyte responsiveness to PMA. In the longitudinal cross-over study, the 8-OHdG level significantly decreased, and blood lipid-adjusted plasma alpha-tocopherol increased after switching the cellulose membrane to CL-E or synthetic membrane for eight weeks. In contrast, the 8-OHdG level dramatically rose, and blood lipid-adjusted plasma alpha-tocopherol declined after shift of CL-E or synthetic membrane to the cellulose membrane.

Conclusions: CL-E membrane exhibited biocompatible and bioactive characteristics. Like synthetic membranes, treatment with a CL-E dialyzer effectively reduced the 8-OHdG content in leukocyte DNA, suppressed intracellular ROS production of granulocytes, and preserved the plasma level of vitamin E. It could further improve granulocyte responsiveness to a PMA challenge. Reduced DNA damage and improved immune function of leukocytes may reduce the cancer and infection risks in chronic HD patients.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Adult
  • Aged
  • Ascorbic Acid / blood
  • Biocompatible Materials / therapeutic use
  • Bone Cements / therapeutic use
  • Cellulose / therapeutic use
  • Chromatography, High Pressure Liquid
  • Cross-Over Studies
  • DNA / analysis
  • Deoxyguanosine / analogs & derivatives*
  • Deoxyguanosine / analysis
  • Female
  • Flow Cytometry
  • Humans
  • Hydrogen Peroxide / metabolism
  • Kidney Failure, Chronic / therapy*
  • Leukocytes / chemistry*
  • Leukocytes / metabolism
  • Male
  • Membranes, Artificial*
  • Middle Aged
  • Oxidative Stress / drug effects
  • Polymers / therapeutic use
  • Polymethyl Methacrylate / therapeutic use
  • Prospective Studies
  • Renal Dialysis / instrumentation*
  • Sulfones / therapeutic use
  • Vitamin E / blood
  • Vitamin E / therapeutic use*

Substances

  • Biocompatible Materials
  • Bone Cements
  • Membranes, Artificial
  • Polymers
  • Sulfones
  • Vitamin E
  • polysulfone P 1700
  • 8-Hydroxy-2'-Deoxyguanosine
  • Cellulose
  • DNA
  • Polymethyl Methacrylate
  • Hydrogen Peroxide
  • Deoxyguanosine
  • Ascorbic Acid